Amgen reports positive trial results for high-cholesterol treatment
The portion of Amgen’s Phase 3 trial of evolocumab that evaluated patients with high cholesterol who cannot tolerate statins has met goals related to percent reduction of low-density lipoprotein cholesterol.
Teledyne shares dip despite jump in Q4 profits
Shares of defense and industrial conglomerate Teledyne Technologies sank 1.6 percent in midday trading on Thursday despite higher sales and profits from the Thousand Oaks-based firm.
Amgen enters into deals for colon cancer, IBD treatments
Thousand Oaks-based Amgen has entered into two new collaborations, one involving treatment for colon cancer and another regarding therapies for inflammatory bowel disease.
Amgen’s chief financial officer to depart
Chief Financial Officer Jonathan M. Peacock is leaving Amgen to pursue broader career opportunities, the company announced. Michael A. Kelly has been named acting CFO.
Westlake Village founder’s trust gives $540M to cancer research
Ludwig Cancer Research, started by Westlake Village founding developer Daniel K. Ludwig, has donated $540 million to six U.S. Ludwig Centers on behalf of the late philanthropist’s trust, the organization announced Jan. 6.
Strawberries top tri-county farming forecast in 2014
Strawberries remain the largest piece of the pie in the Tri-Counties’ multibillion-dollar agriculture industry, but there will be slightly less acreage in the New Year.
